default author photo

Jessica Griffith

University of Minnesota - Minneapolis - Department of Pharmaceutics

Minneapolis, MN

United States

SCHOLARLY PAPERS

1

DOWNLOADS

31

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Activation of ­­STAT3 Through Combined SRC and EGFR Signaling Drives Resistance to a Mitotic Kinesin Inhibitor in Glioblastoma

Number of pages: 58 Posted: 21 Jan 2022
Mayo Clinic - Department of Cancer Biology, Columbia University - Department of Pathology and Cell Biology, Columbia University - Irving Medical Center, Vanderbilt University - Department of Biochemistry, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Columbia University - Department of Pathology and Cell Biology, Columbia University - Department of Pathology and Cell Biology, University of Minnesota - Minneapolis - Department of Pharmaceutics, University of Minnesota - Minneapolis - Department of Pharmaceutics, University of Minnesota - Minneapolis - Department of Pharmaceutics, Mayo Clinic - Department of Cancer Biology, Mayo Clinic - Department of Neurosurgery, University of Minnesota - Minneapolis - Department of Pharmaceutics, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Vanderbilt University - Department of Biochemistry, Columbia University - Department of Systems Biology, Columbia University - Department of Pathology and Cell Biology and Mayo Clinic - Department of Cancer Biology
Downloads 31 (1,304,549)
Citation 1

Abstract:

Loading...

kinesin, glioblastoma, STAT3, inhibitor, EGFR, Src